The effects of the inhibition of fatty acid oxidation on pyruvate dehydrogenase complex activity in tissues of lean and obese mice

International Journal of Obesity

Volumn 20, Issue 8, 1996, Pages 738-744

  Bryson, J M ^a   Cooney, G J ^a   Wensley, V R ^a   Phuyal, J L ^a   Caterson, I D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Fatty acid oxidation inhibition; Obesity; PDH complex

Indexed keywords

AUROTHIOGLUCOSE; ETOMOXIR; GLUCOSE; GLYCOGEN; INSULIN; PYRUVATE DEHYDROGENASE COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; HEART; INSULIN BLOOD LEVEL; LIVER; MALE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; OBESITY; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CARNITINE O-PALMITOYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; FATTY ACIDS; GLUCOSE; GLYCOGEN; HOMEOSTASIS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; MICE; MICE, INBRED CBA; MUSCLE, SKELETAL; MYOCARDIUM; OBESITY; OXIDATION-REDUCTION; PYRUVATE DEHYDROGENASE COMPLEX; TIME FACTORS;

ANIMALIA;

EID: 0029778836     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
2. Del Prato S et al. Insulin regulation of glucose and lipid metabolism in massive obesity. Diabetologia 1990; 33: 228-236.
3. Boden G et al. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994; 93: 2438-2446.
4. Vaag AA et al. Glucose-fatty acid cycle operates in humans at the level of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Eur J Endocr 1994; 130: 70-79.
5. Yki-Jarvinen H, Puhakainen I, Koivisto VA. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocr Metab 1991; 72: 1268-1277.
6. Mandarino LJ et al. Fasting hyperglycemia normalises oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocr Metab 1990; 71: 1544-1551.
7. Kelley DE, Mokan M, Mandarino LJ. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 1992; 41: 698-706.
8. Suh KI et al. Intracellular glucose metabolism after long term metabolic control with Glyburide: improved glucose oxidation with unchanged glycogen synthase activity. J Clin Endocr Metab 1993; 77: 464-470.
9. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993; 92: 91-98.
10. Kruszynska YT, McCormack JG, McIntyre N. Effects of non-esterified fatty acid availability on insulin stimulated glucose utilisation and tissue pyruvate dehydrogenase activity in the rat. Diabetologia 1990; 33: 396-402.
11. Bryson JM et al. Tissue differences in the response of the pyruvate dehydrogenase complex to a glucose load during the development of obesity in gold-thioglucose obese mice. Biochem J 1995; 305: 811-816.
12. Bryson JM et al. High fat feeding alters the response of rat PDH complex to acute changes in glucose and insulin. Am J Physiol 1995; 268: E752-E757.
13. Wolf, HPO. Aryl-substituted 2-oxirane carboxylic acids: a new group of antidiabetic drugs. In: Bailey CJ, Flatt PR (eds). New antidiabetic drugs. Smith Gordon: London, 1990, pp 217-226.
14. Kruszynska YT, Sherratt HSA: Glucose kinetics during acute and chronic treatment of rats with 2[6(4-chlorophenoxy)hexyl]oxirane-2-carboxylate, Etomoxir. Biochem Pharmacol 1987; 36: 3917-3921.
15. Barnett M, Collier GR, O'Dea K. The longitudinal effect of inhibiting fatty acid oxidation in diabetic rats fed a high fat diet. Horm Metab Res 1992; 24: 360-362.
16. Li J, Stillman JS, Clore JN, Blackard WG. Skeletal muscle lipids and glycogen mask substrate competition (Randle Cycle). Metabolism 1993; 42: 451-456.
17. Hubinger A, Weikert G, Wolf HPO, Gries FA. The effect of Etomoxir on insulin sensitivity in Type 2 diabetic patients. Horm Metab Res 1992; 24: 115-118.
18. Ratheiser K et al. Inhibition by Etomoxir of carnitine palmitoyltransferase 1 reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus. Metabolism 1991; 40: 1185-1190.
19. Macaulay SL, Larkins RG. Impaired insulin action in adipocytes of New Zealand Obese mice: a role for postbinding defects in pyruvate dehydrogenase and insulin mediator activity. Metabolism 1988; 37: 958-965.
20. Caterson ID et al. The effect of body weight and the fatty acid-oxidation inhibitor 2-tetradecylglycidic acid on pyruvate dehydrogenase complex activity in mouse heart. Biochem J 1984; 224: 787-791.
21. Collier GR, Traianedes K, Macaulay SL, O'Dea K. Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats. Horm Metab Res 1993; 25: 9-12.
22. Jenkins AB et al. Effects of blockade of fatty acid oxidation on whole body and tissue-specific glucose metabolism in rats. Am J Physiol 1993; 265: E592-E600.
23. Blair SC, Caterson ID, Cooney GJ. Insulin response to an intravenous glucose load during development of obesity in gold thioglucose-injected mice. Diabetes 1993; 42, 1153-1158.
24. Le Marchand Y, Freychet P, Jeanrenaud B. Longitudinal study on the establishment of insulin resistance in hypothalamic obese mice. Endocrinology 1978; 102: 74-85.
25. Denyer GS et al. Heterogeneity of response to exercise of rat muscle pyruvate dehydrogenase complex. Eur J Physiol 1991; 419: 115-120.
26. Kerbey AL et al. Regulation of pyruvate dehydrogenase in rat heart. Biochem J 1976; 154: 327-348.
27. Denyer GS, Lam D, Cooney GJ, Caterson ID. Effect of starvation and insulin in vivo on the activity of the pyruvate dehydrogenase complex in rat skeletal muscles. FEBS Letts 1989; 250: 464-468.
28. Caterson ID et al. The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance. Biochem J 1987; 243: 549-553.
29. Chan TM, Exton JH. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 1976; 71: 96-105.
30. Bryson JM et al. Diurnal patterns of cardiac and hepatic pyruvate dehydrogenase complex activity in gold thioglucose obese mice. Biochem J 1993; 295: 731-734.
31. Chen C, Williams PF, Cooney GJ. Caterson ID. Diurnal rhythms of glycogen metabolism in the liver and skeletal muscle in gold thioglucose induced-obese mice with developing insulin resistance. Int J Obesity 1992; 16: 913-921.
32. Cooney GJ et al. In vivo insulin sensitivity of the pyruvate dehydrogenase complex in tissues of the rat. Am J Physiol 1993; 265: E102-E107.
33. McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity for carnitine, and malonyl CoA sensitivity, of carnitine palmitolytransferase 1 in animal and human tissues. Biochem J 1983; 214: 21-28.
34. McGarry JD, Woeltje KF, Kuwajima M, Foster DW. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev 1989; 5: 271-284.
35. y mouse: effects of pioglitazone on malonyl-CoA and diaglycerol. Am J Physiol 1994; 267: E95-E101.
36. Saggerson S, Ghadiminejad I, Awan M. Regulation of mitochondrial carnitine palmitoyl transferases from liver and extrahepatic tissues. Adv Enzyme Regul 1992; 32: 285-306.
37. Wititsuwannakul D, Kim KH. Mechanism of palmityl Coenzyme A inhibition of liver glycogen synthase. J Biol Chem 1977; 252: 7812-7817.